Development of a new anti-inflammatory peptide for treatment of type II diabetes

Ended Project Grant Awarded Last action

Award ID
R43DK101203
Recipient
Awarding agency
Obligated
$188,508

Award facts

Assistance listing
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
Completion date
Place of performance
Manassas, VA 20110, USA

Award details come from USAspending.gov.

Quick answers

Who received award R43DK101203?

R43DK101203 was awarded to Serpin Pharma, LLC by National Institutes of Health (Department of Health and Human Services) on August 1, 2014.

How much is award R43DK101203 worth?

$188,508 has been obligated on R43DK101203.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award